Last night I came across a cool website that highlighted a contest announced by the California Institute for Regenerative Medicine (CIRM). The winners of the 2008 stem cell image contest have just been announced.
The winning images range from
a whirling galaxy of developing nerve cells to a moonscape of retinal
pigment epithelial cells, both derived from human embryonic stem cells you can see more on the website, including beautiful photos like this one, which they have uploaded to Flickr for viewing:
The institute was established in 2005 with the passage of Proposition 71, the
California Stem Cell Research and Cures Act:
"The statewide ballot
measure, which provided $3 billion in funding for stem cell research at
California universities and research institutions, was overwhelmingly
approved by voters, and called for the establishment of an entity to
make grants and provide loans for stem cell research, research
facilities, and other vital research opportunities. To date, the CIRM
governing board has approved 279 research and facility grants totaling
more than $693 million, making CIRM the largest source of funding for
human stem cell research in the world."
A smart approach by Californians, and a good idea of CIRM to keep members of the public updated on progress with the research and how the dollars are spent. If only the finance and banking industry was as open and forthcoming with transparency ;-)
TrackBack
TrackBack URL for this entry: http://www.typepad.com/services/trackback/6a00d8342ae08153ef01127909d51728a4
You can follow this conversation by subscribing to the comment feed for this post.
The comments to this entry are closed.
Publisher
This blog is published by: Sally Church, PhD of Icarus Consultants, Inc. The contents of this blog are the intellectual property of the author and all rights are reserved. No commercial use, copying or distribution is permitted without the author's express permission.
Become a Fan
What we do
Icarus Consultants is a management consulting company focusing on marketing strategy and new product development to the Pharma and Biotech industry. We focus on specialist areas such as oncology, hematology, immunology, respiratory and HIV.
Our particular areas of interest include social media monitoring, key opinion leader research, competitive intelligence and landscape opportunity assessments. We use primary qualitative market research and buzz metrics to support our strategic analyses.
Company Web Site
![Reblog this post [with Zemanta]](http://img.zemanta.com/reblog_e.png?x-id=fdc42d69-4483-411e-8583-09e6f0896e30)
Comments